Enhancing R&D productivity in MidPharma

On the 24^th and 25^th April, we had the pleasure of hosting our annual face-to-face MidPharma R&D Symposium in London, the first since the COVID-19 pandemic. The event began with a networking dinner on the evening of the 24^th followed by facilitated discussions on the 25^th.

The symposium was attended by 13 R&D Leaders from 9 European-headquartered MidPharmas.

We facilitated sub-group discussions on how to enhance R&D productivity, with a focus on:

• • Enhancing productivity of the project-function matrix

• • Optimising decision-making and capabilities

• • Blending external and internal innovation

From our lively and fascinating Chatham House Rule discussions, it was clear that MidPharmas which pilot or implement new ways to address R&D challenges are those that have the best chance of success. Simply living with challenges is not an option.

This article, published in MedNous, summarises the key insights from the discussion.

We are already looking forward to hosting our R&D symposium next year. Please contact John Rountree, Andrew Bell or John Gregson for more information or to request an invitation.